Mustang Bio, Inc (MBIO)

Etorro trading 970x250
Mustang Bio, Inc (MBIO) Logo

About Mustang Bio, Inc

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develop MB-107, a gene therapy program, potential curative treatment for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. Its ex vivo lentiviral gene therapy is in two Phase 1/2 clinical trials. The company also develops MB-102, a heterodimeric interleukin-3-receptor for acute myeloid leukemia; MB-106 for immunotherapy of B-cell lymphomas; MB-104, an NK cell receptor regulating immune functions; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has a license agreement with Nationwide Children’s Hospital for the development of an oncolytic virus for treating GBM; and Beth Israel Deaconess Medical Center, Inc. to perform research relating to gene editing. The company was incorporated in 2015 and is headquartered in New York, New York. Mustang Bio, Inc. is a subsidiary of Fortress Biotech, Inc. Address: 377 Plantation Street, Worcester, MA, United States, 01605

Mustang Bio, Inc News and around…

Latest news about Mustang Bio, Inc (MBIO) common stock and company :

First Week of MBIO June 2022 Options Trading
18 Oct, 2021 FinancialContent

Investors in Mustang Bio Inc (MBIO) saw new options begin trading this week, for the June 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Here's What Mustang Bio, Inc.'s (NASDAQ:MBIO) Shareholder Ownership Structure Looks Like
06 Oct, 2021 Yahoo! Finance

The big shareholder groups in Mustang Bio, Inc. ( NASDAQ:MBIO ) have power over the company. Institutions often own...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Mustang Bio, Inc. (MBIO): Hedge Funds In Wait-and-See Mode
04 Oct, 2021 Yahoo! Finance

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]

Mustang Bio to Participate in Chardan’s Virtual 5th Annual Genetic Medicines Conference
30 Sep, 2021 FinancialContent
Mustang Bio Announces MB-101 (IL13Rα2‐targeted CAR T cells) Scientific Presentations at Upcoming Virtual Conferences
28 Sep, 2021 FinancialContent

Christine Brown, Ph.D., of City of Hope will present at the First Annual Conference on CNS Clinical Trials Co-sponsored by SNO and ASCO and the AACR Virtual Special Conference: Brain Cancer

Mustang Bio (MBIO) Sees Hammer Chart Pattern: Time to Buy?
24 Sep, 2021 Yahoo! Finance

Mustang Bio (MBIO) has been struggling lately, but the selling pressure may be coming to an end soon.

Look Under The Hood: IWN Has 19% Upside
16 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell 2000 Value ETF (IWN), we found that the implied analyst target price for the ETF based upon its underlying holdings is $191.83 per unit.

Mustang Bio to Participate in Three September 2021 Investor Conferences
09 Sep, 2021 FinancialContent
Reddit Penny Stocks to Buy? 3 That You Probably Don’t Know About
16 Aug, 2021 FinancialContent
Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights
16 Aug, 2021 FinancialContent
Mustang Bio, Mayo Clinic Join Forces On New CAR T Tech In Tumor Settings
13 Aug, 2021 FinancialContent

Mustang Bio Inc(NASDAQ: MBIO)executed an exclusive license agreementwithMayo Clinicfor a new approach ...

Mustang Bio Collaborates with Mayo Clinic on Novel CAR T Technology
12 Aug, 2021 FinancialContent
Mustang Bio Collaborates with Mayo Clinic on Novel CAR T Technology
12 Aug, 2021 Yahoo! Finance

The exclusively licensed platform has potential application for any tumor target Preclinical development to continue at Mayo Clinic Mustang to file IND upon identification of a lead CAR construct WORCESTER, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic disease

Are These Penny Stocks Worth Watching This Week? 3 For Your List
09 Aug, 2021 FinancialContent
Trade Alert: The President Of Mustang Bio, Inc. (NASDAQ:MBIO), Manuel Litchman, Has Just Spent US$251k Buying 9.9% More Shares
07 Aug, 2021 Yahoo! Finance

Investors who take an interest in Mustang Bio, Inc. ( NASDAQ:MBIO ) should definitely note that the President, Manuel...

5 Best Penny Stocks To Buy Right Now According To Insiders
06 Aug, 2021 FinancialContent
3 Penny Stocks Insiders Are Buying
06 Aug, 2021 FinancialContent

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

12 Health Care Stocks Moving In Thursday's After-Market Session
05 Aug, 2021 FinancialContent

Gainers Sensus Healthcare (NASDAQ:SRTS) shares moved upwards by 18.07% to $4.18 during Thursday's after-market session. This ...

Mustang Bio's Gene Therapy For Genetic Immunodeficiency Receives European PRIME Tag
02 Aug, 2021 FinancialContent

TheEuropean Medicines Agency has granted Priority Medicines designationtoMustang Bio Inc's(NASDAQ: MBIO) ...

Mustang Bio Receives European Medicines Agency PRIME Designation for MB-107 to Treat X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
02 Aug, 2021 FinancialContent
First Week of MBIO March 2022 Options Trading
16 Jul, 2021 FinancialContent

Investors in Mustang Bio Inc (MBIO) saw new options begin trading this week, for the March 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

15 Best Penny Stocks to Buy Now
14 Jul, 2021 Yahoo! Finance

In this article, we discuss the 15 best penny stocks to buy now. If you want to skip our detailed analysis of these companies, go directly to the 5 Best Penny Stocks to Buy Now. Many novice investors are bullish on penny stocks with growth potential for capital appreciation. All iconic stocks were once penny […]

Top Buys by Directors: Litchman, M.D.'s $516.6K Bet on MBIO
18 Jun, 2021 FinancialContent

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..

Mustang Bio Awarded Massachusetts Life Sciences Center Tax Incentive
17 Jun, 2021 FinancialContent
Mustang Bio to Present at the Raymond James Human Health Innovation Conference
16 Jun, 2021 FinancialContent
Here's Why We're Not Too Worried About Mustang Bio's (NASDAQ:MBIO) Cash Burn Situation
15 Jun, 2021 Yahoo! Finance

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts
13 Jun, 2021 FinancialContent
8 Health Care Stocks Showing Unusual Options Activity In Today's Session
11 Jun, 2021 FinancialContent

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ...

Mustang Bio, Inc (MBIO) is a NASDAQ Common Stock listed in , ,

970x250